Lialda uses are focused on the treatment of mild to moderately active ulcerative colitis in adults. By inhibiting the production of inflammatory chemicals in the lining of the colon, the medicine can significantly improve symptoms of ulcerative colitis. Healthcare providers may also occasionally recommend the medication for treating other conditions. These "off-label" Lialda uses may include the treatment of Crohn's disease.
Lialda® (mesalamine) is a prescription medicine that has been licensed to treat ulcerative colitis. It is part of a group of medications known as aminosalicylates.
Ulcerative colitis is a type of inflammatory bowel disease (IBD) that leads to inflammation and sores in the lining of the large intestine and rectum. It commonly causes abdominal pain, diarrhea, and other symptoms, like rectal bleeding or an extreme urgency to have a bowel movement. At this time, the causes of ulcerative colitis are not fully understood. Although ulcerative colitis complications can be quite severe, there is only one ulcerative colitis cure -- surgery. Other than surgery (see Ulcerative Colitis Surgery), ulcerative colitis treatment options include the following:
- Medications (see Ulcerative Colitis Medication)
- Dietary changes (see Ulcerative Colitis Diet)
- Lifestyle changes (see Living With Ulcerative Colitis)
- A combination of these options.
Lialda is approved to treat mild to moderately active ulcerative colitis, helping to reduce the symptoms seen with the condition. It is used both to "induce remission" (cause the disease to at least temporarily go away) and to "maintain remission" (keep it from coming back).